Performance of controlled attenuation parameter (CAP) to assess steatosis in a large prospective multicentre UK study of patients with non-alcoholic fatty liver disease (NAFLD)

P Eddowes, M Allison, E Tsochatzis, Q Anstee, D Sheridan, IN Guha, J Cobbold, V Paradis, P Bedossa, P Newsome

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Apr 2018

Cite this